Theriva Biologics TOVX
NYSE TOVX
$0.21 0.00 (-0.72%)
As of: Oct 21, 2026 · 1:38 PM EDT

Theriva Biologics (TOVX) Operating Margin (2010 - 2026)

Updated

Theriva Biologics' Operating Margin came in at -709.00% for Q1 2026.

Analysis

Theriva Biologics (TOVX) Operating Margin (2010 - 2026) Analysis & Trends

Going back to Q2 2010, Theriva Biologics' Operating Margin data covers 5 quarters.

  • The Q1 2026 figure represents the highest quarterly Operating Margin since Q3 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 28.21%
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 37.86%
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn 20.57%
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn -133.21%
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn 28.37%
10 Theriva Biologics 9.48 Mn -36.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -709.00%
Sep 30, 2011 -319.76%
Jun 30, 2011 -258.61%
Sep 30, 2010 -252.89%
Jun 30, 2010 44.34%
API Access

Theriva Biologics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=TOVX&period=max&api_key=YOUR_API_KEY